Bugs, Drugs & Beyond: Targeting the Microbiome to Transform Health Care

Wednesday, March 1, 2017 | 8:45 a.m. - 4:00 p.m. Add to Calendar

The microbiome represents a dramatically new frontier in medicine, providing a vast array of potential targets and mechanisms through which we may harness the body’s naturally-occurring responses to treat disease and maintain health. Join the Janssen Human Microbiome Institute and JLABS @ TMC for a one-day forum to explore the ways in which innovators from Houston and beyond are harness the human microbiome and advancing novel therapeutics, diagnostics and other health products. During this event, we’ll hear from entrepreneurs, academics, investors, and biotech and pharma companies about a variety of product development approaches and the organizations pursuing them. Interactive sessions will highlight: Challenges in advancing to market, from IP protection to commercialization Potential solutions and pathways currently being pursued across the field Opportunities for collaboration Speakers: Dirk Gevers | Global Head, Janssen Human Microbiome Institute, Janssen R&D read bio» Additional Speakers To Be Confirmed Agenda: 8:45 AM | Registration Opens 9:00 AM | Introductions 9:00 AM | Big Pharma’s Gut Feeling on the Human Micorbiome: – Exploring the spectrum of Microbiome-based Therapeutics 10:00 AM | Insights from the Front Lines of Microbiome Innovation 10:45 AM | Networking Break 11:15 AM | From Regulatory to Commercialization: – Breaking down barriers to Microbiome Progress 12:30 PM | Networking Lunch 1:30 PM | Microbiome Gallery Walk – Take a tour throughout some of the most exciting micorbiome innovation 2:30 PM | Networking Break 2:45 PM | Pitch Your Microbiome Pitch Slams 4:00 PM | Program Ends



2450 Holcombe Blvd. Ste. J, Houston, TX


Raquel Longley